At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
St. Jude Medical renal artery ablation system: RF ablation generator (IBI 1500T11.5) and Renal artery ablation catheter (DS3D001, DS3D002)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ablation-induced Renal Sympathetic Denervation Trial
In Brief
A clinical study evaluating St. Jude Medical renal artery ablation system: RF ablation generator (IBI 1500T11.5) and Renal artery ablation catheter (DS3D001, DS3D002) for Hypertension. Completed, enrolled 47 participants across 4 sites in 2 countries.
Detailed Summary
This is a prospective, multicenter, feasibility study on the safety and efficacy of renal denervation in patients with resistant hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesAustralia, Greece
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 2011
Enrollment StartOct 2011
Primary CompletionSep 2012
Study CompletionJul 2014
TodayJul 2026
First PostedSep 22, 2011
Enrollment StartOct 1, 2011
Primary CompletionSep 1, 2012
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 14.8 years ago
Interventions
St. Jude Medical renal artery ablation system: RF ablation generator (IBI 1500T11.5) and Renal artery ablation catheter (DS3D001, DS3D002)device
Catheter-based RF ablation in renal artery